Body Language Critical During Breast Cancer Chemotherapy

Experts have used an Italian study to achieve a universal standard when measuring a cancer patient’s distress towards their appearance, to allow physicians and psychologists to recommend the next step in treatment.

A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24 (DAS24), an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.

The study, published in the April 2016 issue of the medical journal Anticancer Research, builds upon the successful transition of the scale across various languages and cultures in both its longer (DAS59) and shorter (DAS24) versions. This represents an important tool, providing surgeons and psychologists with a proven method that gains insight into the levels of distress patients and clients are encountering, thus guiding the direction of the patients treatment plan.

Rest of news release            PubMed Abstract